Astrazeneca (AZN) Shares Outstanding (2009 - 2026)

Astrazeneca has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $1.6 billion in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $1.6 billion in Q4 2025; TTM through Dec 2025 was $1.6 billion, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.6 billion, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was $1.6 billion for Q4 2025 at Astrazeneca, roughly flat from $1.6 billion in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $1.6 billion in Q4 2024, with the low at $1.5 billion in Q4 2022.
• Average Shares Outstanding (Entity) over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) increased 18.09% in 2021, then slipped 0.09% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $1.5 billion in 2021, then slipped by 0.09% to $1.5 billion in 2022, then advanced by 0.06% to $1.5 billion in 2023, then gained by 0.06% to $1.6 billion in 2024, then changed by 0.0% to $1.6 billion in 2025.
• The last three Shares Outstanding (Entity) figures came in at $1.6 billion (Q4 2025), $1.6 billion (Q4 2024), and $1.5 billion (Q4 2023), per Business Quant data.